The Video-Based Exercise Program in Degenerative Meniscus Tears
Launched by ISTANBUL UNIVERSITY - CERRAHPASA · Feb 28, 2022
Trial Information
Current as of July 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
To investigate the efficacy of a video-based exercise program, voluntary patients with degenerative meniscus tears, aged between 40 and 65 years, will be randomly divided into two groups: the video-based exercise (VBE) group and the standard exercise (SE) group. Interventions will be applied for 16 sessions (twice a week for eight weeks). The patients will be assessed at baseline and the end of the 8-week intervention. The pain during activity, at rest, and night will be assessed with the Visual Analog Scale (VAS). The active range of motion will be evaluated with a digital goniometer. Isom...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Being aged between 40 and 65 years
- • Having the degenerative meniscus tear in at least one knee
- • Having body mass index in the range of 18-30 kg/m2
- • Feeling the pain that lasts for at least 2 months
- • Having grade 1 or grade 2 degenerative meniscal tear diagnosed by an orthopedic specialist according to the MRI results
- • Having the activity level is between 1 and 5 according to the Tegner Activity Scale
- • Having the ability to read and write Turkish
- Exclusion Criteria:
- • Having undergone arthroscopic partial meniscectomy surgery due to degenerative meniscal tear
- • Participating in a physiotherapy program for degenerative meniscal tear in the last 12 weeks
- • Have received steroid injections in the last 6 months
- • Accompanying conditions such as injury to the surrounding ligaments, congenital anomaly in the affected knee, coxarthrosis and spinal stenosis
- • Presence of any systemic disorder that may affect assessment parameters
- • Failure to cooperate with assessments
- • Any vision or hearing problem that would prevent them from adapting to the assessment
About Istanbul University Cerrahpasa
Istanbul University - Cerrahpasa is a prestigious academic institution renowned for its commitment to advancing medical research and education. With a focus on innovative clinical trials, the university harnesses cutting-edge methodologies to address pressing health challenges. Its collaborative environment fosters interdisciplinary research, enabling the development of effective therapeutic strategies and enhancing patient care. The institution's dedication to ethical standards and patient safety underscores its reputation as a leader in clinical research within the region and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Istanbul, Bakırkoy, Turkey
Istanbul, , Turkey
Istanbul, , Turkey
Patients applied
Trial Officials
Tansu Birinci, PhD, PT
Principal Investigator
Istanbul University - Cerrahpasa
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials